GLP1 is a hormone which can reduce the glucagon:insulin ratio and is higher in female mice, a model of protection from olanzapine-induced hyperglycemia, compared to male or ovariectomized mice (Medak et al., 2019), (Handgraaf et al., 2018). Here, GCG is linked to Hyperglycemia.